Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevent...

von Weisman, Leonard E., Thackray, Helen M., Garcia-Prats, Joseph A., Nesin, Mirjana, Schneider, Joseph H., Fretz, Jennifer, Kokai-Kun, John F., Mond, James J., Kramer, William G., Fischer, Gerald W.
Veröffentlicht 2009